Results 41 to 50 of about 12,776,512 (310)

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak   +9 more
wiley   +1 more source

AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways

open access: yesALTEX: Alternatives to Animal Experimentation, 2020
New approaches, like the adverse outcome pathway (AOP) framework, have been developed to describe how chem­icals cause toxicity by linking in vitro assays to adverse health outcomes.
Taylor E. Rycroft   +7 more
doaj   +1 more source

20220110_RAG_Risk assessment pandemic law_NL

open access: yes, 2022
RAG RA pandemic law 10-01 ...
Risk Assessment Group
core  

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

From pathways to people: Applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment

open access: yesALTEX: Alternatives to Animal Experimentation, 2013
Consumer safety risk assessment of skin sensitization requires information on both consumer exposure to the ingredient through product use and the hazardous properties of the ingredient.
Cameron MacKay   +3 more
doaj   +1 more source

Metabolic profiling and in vitro-in vivo extrapolation of furathiocarb in mammalian hepatic microsomes

open access: yesToxicology Reports, 2022
Furathiocarb is a carbamate insecticide found in marine ecosystems as well as river water and sediments. The aim of this study was to characterize species differences in the in vitro metabolism of furathiocarb in seven mammalian species (human, monkey ...
Khaled Abass   +4 more
doaj   +1 more source

20220110_RAG_Risk assessment pandemic law_FR

open access: yes, 2022
RAG RA pandemic  ...
Risk Assessment Group
core  

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

open access: yesFEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

20220228_RAG_Risk assessment pandemic law_FR

open access: yes, 2022
RAG RA pandemic  ...
Risk Assessment Group
core  

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy